Novel Protein Kinase D inhibitors

Be the first to comment!

>> Saturday, June 19, 2010

As we are going to talk about the Protein Kinase D inhibitors, let’s understand the basic about the protein kinases. Actually they are the enzymes which catalyze protein phosphorylation, i.e., the transfer of the gamma-phosphoryl group of ATP to tyrosine, serine and threonine residues in protein substrates. Phosphorylation can result in activation / inhibition of an enzyme, conformational changes or creation of surface with distinct binding properties. Thus, protein phosphorylation has great role in various cellular processes and defect in this process can result in many diseases including cancer and inflammation.

Quick look at Drug discovery opinion (DDO)

2 Comments so far

>> Wednesday, June 02, 2010

This post includes candid talk with Mr. Bill Harris, founder of Drug discovery opinion (DDO). Last month, medchemblog conducted polling for favorite blog. Drug discovery opinion (DDO) got the highest vote (42%). Let me introduce the blog. It’s a nice blog with recent updates on drug discovery and development. It was established in 2008 by medicinal chemists, Mr. Bill Harris and Ms. Sally Redshaw to provide consultancy services to Pharma and Biotech companies. They have many years experience in drug discovery and development working with companies like Roche, GSK and De Novo pharmaceuticals. Authors have clear and concise way of presenting the subject matter. Click on the banner to visit their page.
drug discovery opinion
It’s a great pleasure to present views/opinion from one of the founder of DDO, Mr. Bill Harris. Medchemblog is thankful for his wonderful support and valuable time. Ok, let’s take a look at what he says;

  © Medchemblog, 2009-present Webnolia by 2009

Back to TOP